Traditional Chinese medicine for treating chronic superficial gastritis and helicobacter pylori-associated gastritis

Abstract

The invention relates to the field of formulas of traditional Chinese medicine, and particularly provides a traditional Chinese medicine for treating chronic superficial gastritis and helicobacter pylori-associated gastritis. The traditional Chinese medicine is characterized by comprising the following raw medicines in parts by weight: 4 to 6 parts of perilla stem, 7 to 9 parts of caulis bambusae in taeniam, 8 to 10 parts of oldenlandia diffusa, 12 to 25 parts of radix bupleuri, 12 to 16 parts of dandelion, 10 to 14 parts of folium mori, 10 to 12 parts of sanguisorba officinalis, 12 to 22 parts of bletilla striata, 6 to 8 parts of radix ophiopogonis, 6 to 8 parts of radix aucklandiae, 4 to 6 parts of puffball, 2 to 4 parts of sandalwood, 10 to 15 parts of microcos paniculata, 5 to 9 parts of indigo naturalis, and 15 to 20 parts of rhizoma nardostachyos; and when in use, the raw medicines are soaked in water and then decocted, and then dregs are removed to obtain the filtrate. The traditional Chinese medicine is low in cost of raw materials, high in compliance, has no any toxic and side effects, can fight bacterium and diminish inflammation, and has the effects of enhancing protection factors and adjusting antibody immunity, and can effectively treat chronic superficial gastritis and helicobacter pylori-associated gastritis.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a traditional Chinese medicine for treating chronic superficial gastritis Helicobacter pylori-associated gastritis. Background technique [0002] As we all know, Helicobacter pylori is a microaerophilic Gram-negative bacillus, and the infection rate of the global population is as high as 50%. The four diseases of tissue lymphoma are closely related, and it is considered that the eradication of Helicobacter pylori is extremely important for the treatment of the above four diseases. Helicobacter pylori infection is an important cause of the occurrence and recurrence of chronic active gastritis and peptic ulcer. The treatment of Helicobacter pylori infection has always been the focus and hotspot in the field of Helicobacter pylori research. The eradication of Helicobacter pylori in modern medicine mainly uses a proton pump inhibitor or a colloid secretory plus clarithromyci...

AI Technical Summary

Problems solved by technology

However, with the increase of resistant strains of H. pylori, the eradication rate of H. pylori with standard 7- or 10-day triple therapy has gradually declined, and in some areas has dropped below 80%.

At the same time, the occurrence of western medicine resistance, the occurrence of drug toxicity and adverse reactions increased significantly, and the recurrence rate of the disease was high

Images